Oxidative stress in cardiovascular pathologies: Genetics, cellular, and molecular mechanisms and future antioxidant therapies

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Manea, Adrian ^a   Fortuno, Ana ^b   Martin Ventura, Jose Luis ^c  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GINKGO BILOBA EXTRACT; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; SODIUM GLUCOSE COTRANSPORTER 2; THIOREDOXIN; ANTIOXIDANT; CARDIOTONIC AGENT;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; EDITORIAL; GENETICS; HEART PROTECTION; HISTOPATHOLOGY; MOLECULAR MECHANICS; OXIDATIVE STRESS; PROTEIN FUNCTION; ANIMAL; CALCIUM SIGNALING; CELL AGING; DISEASE MODEL; DRUG EFFECT; HEART MUSCLE CELL; HUMAN; MOLECULAR BIOLOGY; MOUSE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ANIMALS; ANTIOXIDANTS; CALCIUM SIGNALING; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CELL AGING; DISEASE MODELS, ANIMAL; HUMANS; MICE; MOLECULAR BIOLOGY; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS;

EID: 84872782389     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/373450     Document Type: Editorial

References (10)

1. Heistad D. D., Wakisaka Y., Miller J., Chu Y., Pena-Silva R., Novel aspects of oxidative stress in cardiovascular diseases. Circulation Journal 2009 73 2 201 207 2-s2.0-59449096216 10.1253/circj.CJ-08-1082
2. Simionescu M., Implications of early structural-functional changes in the endothelium for vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2 266 274 2-s2.0-33846457372 10.1161/01.ATV.0000253884.13901.e4 (Pubitemid 46143039)
3. Madrigal-Matute J., Fernandez-Garcia C. E., Gomez-Guerrero C., Lopez-Franco O., Munoz-Garcia B., Egido J., Blanco-Colio L. M., Martin-Ventura J. L., HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. Cardiovascular Resarch 2012 95 1 116 123 10.1093/cvr/cvs158
4. Fortuño A., Bidegain J., Baltanás A., Moreno M. U., Montero L., Landecho M. F., Beloqui O., Díez J., Zalba G., Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications. Journal of Hypertension 2010 28 9 1944 1950 2-s2.0-77955850314 10.1097/HJH.0b013e32833c21af
5. Manea A., Simionescu M., Nox enzymes and oxidative stress in atherosclerosis. Frontiers in Bioscience 2012 4 651 670
6. Manea A., NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell and Tissue Research 2010 342 3 325 339 10.1007/s00441-010-1060-y
7. Montezano A. C., Touyz R. M., Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Canadian Journal of Cardiology 2012 28 3 288 295 10.1016/j.cjca.2012.01.017
8. Förstermann U., Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nature Clinical Practice Cardiovascular Medicine 2008 5 6 338 349 2-s2.0-44449162751 10.1038/ ncpcardio1211 (Pubitemid 351761708)
9. Fearon I. M., Faux S. P., Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. Journal of Molecular and Cellular Cardiology 2009 47 3 372 381 2-s2.0-67650735222 10.1016/j.yjmcc.2009.05.013
10. Fenyo I. M., Florea I. C., Raicu M., Manea A., Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice. Vascular Pharmacology 2011 54 3-6 100 106 2-s2.0-79957933001 10.1016/j.vph.2011.03.006